Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeStance Health (LFST) EBIT Margin (2020 - 2025)

LifeStance Health (LFST) has disclosed EBIT Margin for 6 consecutive years, with 0.91% as the latest value for Q4 2025.

  • Quarterly EBIT Margin fell 723.0% to 0.91% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.18% through Dec 2025, up 115.0% year-over-year, with the annual reading at 0.18% for FY2025, 115.0% up from the prior year.
  • EBIT Margin for Q4 2025 was 0.91% at LifeStance Health, down from 2.04% in the prior quarter.
  • The five-year high for EBIT Margin was 54.02% in Q4 2021, with the low at 71.72% in Q3 2021.
  • Average EBIT Margin over 5 years is 11.09%, with a median of 8.54% recorded in 2023.
  • The sharpest move saw EBIT Margin plummeted -7435bps in 2021, then skyrocketed 5386bps in 2022.
  • Over 5 years, EBIT Margin stood at 54.02% in 2021, then plummeted by -137bps to 20.06% in 2022, then skyrocketed by 43bps to 11.5% in 2023, then skyrocketed by 155bps to 6.32% in 2024, then crashed by -114bps to 0.91% in 2025.
  • According to Business Quant data, EBIT Margin over the past three periods came in at 0.91%, 2.04%, and 0.85% for Q4 2025, Q3 2025, and Q2 2025 respectively.